Ethnic disparities in survival and progression among EGFR-mutated adenocarcinoma of lung cancer patients treated with tyrosine kinase inhibitors: a systematic review and meta-analysis

Simple item page
dc.contributor.authorFrancisco Cézar Aquino de Moraes
dc.contributor.authorAnna Luíza Soares de Oliveira Rodrigues
dc.contributor.authorEric Pasqualotto
dc.contributor.authorJéssica Fernanda Cassemiro
dc.contributor.authorJhonny Limachi-Choque
dc.contributor.authorRommel Mário Rodríguez Burbano
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T21:05:17Z
dc.date.available2026-03-22T21:05:17Z
dc.date.issued2025
dc.descriptionCitaciones: 1
dc.identifier.doi10.1007/s12094-024-03843-4
dc.identifier.urihttps://doi.org/10.1007/s12094-024-03843-4
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/85853
dc.language.isoen
dc.publisherSpringer Science+Business Media
dc.relation.ispartofClinical & Translational Oncology
dc.sourceUniversidade Federal do Pará
dc.subjectMedicine
dc.subjectInternal medicine
dc.subjectLung cancer
dc.subjectHazard ratio
dc.subjectMeta-analysis
dc.subjectOncology
dc.subjectConfidence interval
dc.subjectAdverse effect
dc.subjectRelative risk
dc.subjectAdenocarcinoma
dc.titleEthnic disparities in survival and progression among EGFR-mutated adenocarcinoma of lung cancer patients treated with tyrosine kinase inhibitors: a systematic review and meta-analysis
dc.typereview

Files

Collections

Artículo Científico Publicado